Literature DB >> 15159397

BRCA1-BARD1 complexes are required for p53Ser-15 phosphorylation and a G1/S arrest following ionizing radiation-induced DNA damage.

Megan Fabbro1, Kienan Savage, Karen Hobson, Andrew J Deans, Simon N Powell, Grant A McArthur, Kum Kum Khanna.   

Abstract

BRCA1 is a major player in the DNA damage response. This is evident from its loss, which causes cells to become sensitive to a wide variety of DNA damaging agents. The major BRCA1 binding partner, BARD1, is also implicated in the DNA damage response, and recent reports indicate that BRCA1 and BARD1 co-operate in this pathway. In this report, we utilized small interfering RNA to deplete BRCA1 and BARD1 to demonstrate that the BRCA1-BARD1 complex is required for ATM/ATR (ataxia-telangiectasia-mutated/ATM and Rad3-related)-mediated phosphorylation of p53(Ser-15) following IR- and UV radiation-induced DNA damage. In contrast, phosphorylation of a number of other ATM/ATR targets including H2AX, Chk2, Chk1, and c-jun does not depend on the presence of BRCA1-BARD1 complexes. Moreover, prior ATM/ATR-dependent phosphorylation of BRCA1 at Ser-1423 or Ser-1524 regulates the ability of ATM/ATR to phosphorylate p53(Ser-15) efficiently. Phosphorylation of p53(Ser-15) is necessary for an IR-induced G(1)/S arrest via transcriptional induction of the cyclin-dependent kinase inhibitor p21. Consistent with these data, repressing p53(Ser-15) phosphorylation by BRCA1-BARD1 depletion compromises p21 induction and the G(1)/S checkpoint arrest in response to IR but not UV radia-tion. These findings suggest that BRCA1-BARD1 complexes act as an adaptor to mediate ATM/ATR-directed phosphorylation of p53, influencing G(1)/S cell cycle progression after DNA damage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15159397     DOI: 10.1074/jbc.M405372200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Test for interaction between two unlinked loci.

Authors:  Jinying Zhao; Li Jin; Momiao Xiong
Journal:  Am J Hum Genet       Date:  2006-09-21       Impact factor: 11.025

2.  Identifying new human oocyte marker genes: a microarray approach.

Authors:  Stéphan Gasca; Franck Pellestor; Saïd Assou; Vanessa Loup; Tal Anahory; Hervé Dechaud; John De Vos; Samir Hamamah
Journal:  Reprod Biomed Online       Date:  2007-02       Impact factor: 3.828

Review 3.  DNA damage sensing by the ATM and ATR kinases.

Authors:  Alexandre Maréchal; Lee Zou
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

4.  Molecular Signature and Mechanisms of Hepatitis D Virus-Associated Hepatocellular Carcinoma.

Authors:  Giacomo Diaz; Ronald E Engle; Ashley Tice; Marta Melis; Stephanie Montenegro; Jaime Rodriguez-Canales; Jeffrey Hanson; Michael R Emmert-Buck; Kevin W Bock; Ian N Moore; Fausto Zamboni; Sugantha Govindarajan; David E Kleiner; Patrizia Farci
Journal:  Mol Cancer Res       Date:  2018-06-01       Impact factor: 5.852

Review 5.  The human intra-S checkpoint response to UVC-induced DNA damage.

Authors:  William K Kaufmann
Journal:  Carcinogenesis       Date:  2009-09-30       Impact factor: 4.944

6.  IQGAP1 is associated with nuclear envelope reformation and completion of abscission.

Authors:  Audrey T Y Lian; Peter G Hains; Boris Sarcevic; Phillip J Robinson; Megan Chircop
Journal:  Cell Cycle       Date:  2015-04-30       Impact factor: 4.534

7.  Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer.

Authors:  M K Sauer; I L Andrulis
Journal:  J Med Genet       Date:  2005-08       Impact factor: 6.318

8.  53BP1 promotes ATM activity through direct interactions with the MRN complex.

Authors:  Ji-Hoon Lee; Aaron A Goodarzi; Penny A Jeggo; Tanya T Paull
Journal:  EMBO J       Date:  2009-12-10       Impact factor: 11.598

9.  Cep164 is a mediator protein required for the maintenance of genomic stability through modulation of MDC1, RPA, and CHK1.

Authors:  Sudhakar Sivasubramaniam; Xuemin Sun; Yen-Ru Pan; Shaohui Wang; Eva Y-H P Lee
Journal:  Genes Dev       Date:  2008-02-18       Impact factor: 11.361

10.  BRCA1 Expression is an Important Biomarker for Chemosensitivity: Suppression of BRCA1 Increases the Apoptosis via Up-regulation of p53 and p21 During Cisplatin Treatment in Ovarian Cancer Cells.

Authors:  Akiko Horiuchi; Cuiju Wang; Norihiko Kikuchi; Ryosuke Osada; Toshio Nikaido; Ikuo Konishi
Journal:  Biomark Insights       Date:  2007-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.